Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Dostawy produktów leczniczych

Part No. 1: Filgrastim

Part No. 2: Gefitinib

Part No. 3: BCG Vaccine

Part No. 4: Levofolinic Acid

Part No. 5: Imatinib

Part No. 6: Temozolomide

Part No. 7: Hydroxycarbamide

Part No. 8: Carboplatin

Part No. 9: Cisplatin

Part No. 10: Cytarabine

Part No. 11: Docetaxel

Part No. 12: Doxorubicin

Part No. 13: Epirubicin

Part No. 14: Etoposide

Part No. 15: Fluorouracil

Part No. 16: Gemcitabine

Part No. 17: Methotrexate

Part No. 18: Methotrexate

Part No. 19: Mitoxantrone

Part No. 20: Pemetrexed

Part No. 21: Bleomycin

Part No. 22: Dacarbazine

Part No. 23: Methotrexate

Part No. 24: Bicalutamide

Part No. 25: Vincristine

Part No. 26: Trastuzumab

Part No. 27: Fluorouracil

Part No. 28: Busulfan

Part No. 29: Arsenic Trioxide

Part No. 30: Lenalidomide

Part No. 31: Cyclophosphamide

Part No. 32: Trabectedin

Part No. 33: Mesna

Part No. 34: Peginterferon alfa-2a

Part No. 35: Vinorelbine

Part No. 36: Various medicinal products

Part No. 37: Panitumumab

Part No. 38: Denosumab

Part No. 39: Aflibercept

Part No. 40: Bosutinib

Part No. 41: Paclitaxel in the form of a nano-particle albumin-bound complex